BioCentury
ARTICLE | Financial News

IFM Therapeutics raises $27M series A round

June 22, 2016 11:53 PM UTC

Immunotherapy newco IFM Therapeutics Inc. (Cambridge, Mass.) raised $27 million in a series A round led by Atlas Venture and Abingworth. Novartis AG (NYSE:NVS; SIX:NOVN) also participated.

IFM is developing small molecules designed to modulate innate immune system targets to treat cancer and inflammatory diseases by enhancing or suppressing immune responses. The company expects the funding to allow it to begin a clinical study of its lead program to treat solid tumors. ...